Registration for ABC Course 1 (Fall 2026) is now open.
ABOUT
The Addressing Basics in Cancer (ABC) program was designed to provide oncology-specific pharmacy education to healthcare professionals looking for additional education. The course takes advantage of a virtual platform without compromising the necessary interactions with instructors. Lectures are held weekly on Zoom for 1.5 hours and participant/instructor engagement is encouraged.
After 3 successful cohorts of ABC Course 1, the steering committee developed ABC Course 2, which occurred for the first time in January 2024. Course 2 modules build on concepts learnt in the first course and include new topics.
THE STEERING COMMITTEE
The ABC Program was developed by an expert steering committee of oncology pharmacists – Scott Edwards, Glenn Myers and Tina Crosbie (including the addition of Christine Peragine in 2023), and is supported by an unrestricted grant from Apobiologix through the Apobiologix Partnership Program.
_edited.jpg)
Scott Edwards
PharmD, MSc (Oncol)
Tina Crosbie
BScPharm, ACPR, RPh
.png)
Glenn Myers
BScPharm, ACPR, RPh
Christine Peragine
PhD, PharmD, BScPhm, HBSc, RPh
ABC COURSE 1
Stay tuned for future
cohort information!
ABC Course 1 is available to anyone interested in looking to broaden their knowledge on the fundamentals of oncology, supportive care and ways to manage side effects for patients suffering from cancer. While the program is ideal for new pharmacist practitioners, it is open to pharmacists, pharmacy technicians, assistants, students or other healthcare professionals looking for additional education.
Part 1 of the program began in 2021 and has run 6 times with over 200 participants to date from across Canada.¹
ABC COURSE 1
DETAILS
PROGRAM SYLLABUS
TOXICITY AND SUPPORTIVE CARE:
1. Nausea/vomiting and other gastrointestinal (GI) toxicities
2. Drug interactions
3. Hematology toxicities
4. Patient education
5. Dermatological toxicities
6. Immune-mediated adverse events (IMAE)
7. Pain management
8. Oncologic emergencies
9. Melanoma
Complex Care:
10. Complex cases
COURSE DETAILS
TIMING:
-
The course includes a total of 10 weekly sessions.
-
The first 3 sessions will run consecutively on Tuesday evenings from September 22nd - October 6th, 2026.
-
The next 3 sessions will run consecutively on Tuesday evenings from October 20th - November 3rd, 2026.
-
The final 4 sessions will run consecutively on Tuesday evenings from November 17th - December 8th, 2026.
-
The course will run from 7:00pm-8:30pm EST.
LOCATION:
-
The course is virtual and all meetings will be held on Zoom.
-
Sessions are recorded so participants are able to access the material after the live lecture. (See requirements for attendance expectations).
PROGRAM WORK:
-
Before each session:
-
Independent completion of mandatory pre-read material (approximately 30-45 min).
-
-
During each session:
-
Live, didactic presentation by Keynote Speaker.
-
Case presentations and discussion with an expert panel.
-
Presentation slides are available in French and are distributed prior to the live lecture to allow you to follow along.
-
Live polling questions are conducted during each presentation to gauge understanding.
-
Requirements:
-
Pre-requisite: CAPhO Oncology Basics. *must show proof of completion
-
Participants are required to attend 8 out of 10 sessions live-virtual sessions. Attendance is taken at every lecture to ensure all participants meet attendance requirements.
-
Upon completion of the course, participants will receive a certificate of completion indicating the total hours allotted for the course.
FAQs
How do I know if I am eligible?
-
The program is open to anyone interested in learning about oncology pharmacy. Participants should have basic knowledge of oncology and oncology drugs and must meet the prerequisites below.
What are the course prerequisites?
-
Required: Completion of CAPhO Oncology Basics program. *If you are in the process of completing oncology basics at the time of registration, please contact info@ABCOncPharmacy.com to let us know.
-
Suggested: Completion of the BC Cancer Drug Interactions Modules.
-
Suggested: Review CAPhO OFD database and webinars related to program topics.
How much does the program cost?
-
$100 for CAPhO members and $150 for non-CAPhO members. Register for CAPhO at the time of ABC registration for a discounted fee of $75.
Is the program Accredited?
-
No.
WILL I HAVE ACCESS TO ALL COURSE MATERIALS?
-
Yes, all slides will be available prior to each lecture via our course platform. You will also have access to all recordings.
HOW MANY PEOPLE ARE IN THE COURSE?
-
Each cohort aims to have 40-45 participants to ensure all participants can interact with one another and the instructors.